Accelsiors is a scientifically-driven, global, full-service Contract Research Organization (CRO). We support the Pharma industry globally to accelerate and manage every activity across clinical drug development.

Since 2002, we have been committed to providing Sponsors working in highly complex disease indications with the scientific knowledge, regulatory expertise and quality operations necessary to achieve their development objectives. 

Accelsiors expertise includes studies in the following areas: 

•	Biosimilars
•	Complex Generics
•	Endocrinology
•	Hepatology
•	Infectious Disease
•	Inflammatory Disease
•	Nephrology
•	Neurology
•	Oncology
•	Pulmonary 
•	Rare Diseases
•	Rheumatology

We serve a global Customer base, which ranges from emerging biotechnology companies to multi-national pharmaceutical companies. 

Accelsiors is committed to establishing meaningful collaborations with our Sponsors and executing studies, regardless of size and scope, with quality being the key driver in all that we do.

Pharmaceutical

Accelsiors CRO

Mihaly Juhasz

Philippe Andry

Pavel Tumanov

Judit Koranyi

Julia Singer

Vlada Injac

Alicja Gietka

The Leadership Team at Accelsiors CRO provides strategic direction and oversight to ensure the successful execution of complex clinical drug development projects. Comprised of senior executives including the Chief Scientific Officer, Founder & CEO, VP Regulatory Affairs, Chief Operating Officer, Vice President Late Stage Development Unit, and VP Data Management And Data Integration, this team drives scientific integrity, regulatory compliance, operational efficiency, and data integration, fostering meaningful collaborations with global Sponsors to achieve their development objectives.

Leadership Team

Clinical Research

Clinical Data Management Team

Business Development

Leadership Team

About

Team members

Other teams at Accelsiors CRO

Clinical Research

Clinical Data Management Team

Business Development